Neogen (NEOG) Cash & Current Investments (2010 - 2026)

Neogen's (NEOG) quarterly Cash & Current Investments came in at $159.9 million in Q1 2026, up 25.21% year-on-year from $127.7 million in Q1 2025, and up 10.02% quarter-over-quarter from $145.3 million in Q4 2025.

Neogen (NEOG) Cash & Current Investments (2010 - 2026) Analysis & Trends

Neogen's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $159.9 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 25.21% year-over-year to $159.9 million in Q1 2026; TTM through Feb 2026 was $159.9 million, a 25.21% increase from a year earlier, with the FY2025 full-year figure at $129.0 million, down 24.53% from the prior year.
  • Cash & Current Investments rose to $159.9 million in Q1 2026 per NEOG's latest filing, from $145.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $381.1 million in Q2 2022 and bottomed at $120.5 million in Q3 2024.
  • The 5-year median for Cash & Current Investments is $170.9 million (2024), against an average of $210.8 million.
  • Across the five-year window, Cash & Current Investments tumbled 51.59% in 2023 and rose 25.21% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $276.3 million in 2022, then dropped by 16.67% to $230.3 million in 2023, then tumbled by 39.1% to $140.2 million in 2024, then climbed by 3.64% to $145.3 million in 2025, then gained by 10.02% to $159.9 million in 2026.
  • Per Business Quant, the three latest NEOG Cash & Current Investments figures stand at $159.9 million (Q1 2026), $145.3 million (Q4 2025), and $138.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 Neogen 2.03 Bn 1.87 Bn 99.00 Mn 159.90 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 159.90 Mn
Nov 30, 2025 145.34 Mn
Aug 31, 2025 138.88 Mn
May 31, 2025 129.00 Mn
Feb 28, 2025 127.71 Mn
Nov 30, 2024 140.23 Mn
Aug 31, 2024 120.48 Mn
May 31, 2024 170.94 Mn
Feb 29, 2024 168.45 Mn
Nov 30, 2023 230.27 Mn
Aug 31, 2023 239.26 Mn
May 31, 2023 245.57 Mn
Feb 28, 2023 183.21 Mn
Nov 30, 2022 276.34 Mn
Aug 31, 2022 347.71 Mn
May 31, 2022 381.05 Mn
Feb 28, 2022 378.44 Mn
Nov 30, 2021 389.25 Mn
Aug 31, 2021 400.88 Mn
May 31, 2021 381.09 Mn